Biochemical properties, pharmacokinetics and pharmacological response of tiotropium in chronic obstructive pulmonary disease patients

Author： Price David   Sharma Ashish   Cerasoli Frank  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.5, Iss.4, 2009-04, pp. : 417-424

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Formoterol plus tiotropium bromide is more effective than either drug alone in patients with acute exacerbation of chronic obstructive pulmonary disease

By  

Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Budesonide/Formoterol Added to Tiotropium Bromide versus Placebo Added to Tiotropium Bromide in Patients with Chronic Obstructive Pulmonary Disease: Australian, Canadian and Swedish Healthcare Perspectives

By Mittmann Nicole  

PharmacoEconomics, Vol. 29, Iss. 5, 2011-05 ,pp. : 403-414

Adis International

Access to resources Recommend Favorite

Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease

By ZuWallack Alicia R   ZuWallack Richard L  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 8, 2004-08 ,pp. : 1827-1835

Informa Healthcare

Access to resources Recommend Favorite

Tiotropium Bromide Inhalation Powder: A Review of its Use in the Management of Chronic Obstructive Pulmonary Disease

By Keating Gillian M.  

Drugs, Vol. 72, Iss. 2, 2012-01 ,pp. : 273-300

Adis International

Access to resources Recommend Favorite

Management of Insomnia in Patients With Chronic Obstructive Pulmonary Disease

By George C.F.P.  

Drugs, Vol. 63, Iss. 4, 2003-01 ,pp. : 379-387

Adis International

Access to resources Recommend Favorite